Biotechnology Jobs in London

144 jobs

Results

Novartis logo

Novartis

Clinical Biospecimen Senior Scientist

  • London
  • Hybrid
  • €46,300 – €86,100 pa
  • Senior

Oversees end-to-end operational execution of biospecimen strategy for clinical trials of standard to medium complexity, covering safety, pharmacokinetics and biomarker samples. Manages sample logistics, laboratory setup, consent and ethical compliance, data transfer and close-out activities, working with internal stakeholders and vendors. Hybrid role with 12 days per month onsite.

CRFs

4 days ago
Novartis logo

Novartis

Clinical Biospecimen Senior Scientist

  • Dublin, Ireland
  • Hybrid
  • €46,300 – €86,100 pa
  • Senior

Responsible for the end-to-end operational execution of biospecimen strategy across clinical trials of standard to medium complexity, covering safety, pharmacokinetics and biomarker samples. Involves sample management and logistics, lab oversight, protocol and consent input, and data reconciliation with internal teams and vendors. Hybrid role with 12 days per month onsite.

4 days ago

GSK · 10000+ people · Public

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

  • Waltham, United States
  • Hybrid · 2 days in office
  • US$340,500 – US$567,500 pa
  • Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.

mRNA · Personalized Vaccine Manufacturing · Checkpoint Inhibitors

Last month

GSK · 10000+ people · Public

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

  • Stevenage
  • Hybrid · 2 days in office
  • US$340,500 – US$567,500 pa
  • Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.

mRNA · Checkpoint Inhibitors

Last month
Recursion logo

Recursion · 501–1000 people · Series C

Vice President, Clinical Pharmacology & Pharmacometrics

  • New York, United States
  • Hybrid
  • US$321,800 – US$443,080 pa
  • Director · manages people

Sets enterprise strategy for clinical pharmacology, pharmacometrics and model-informed drug development across a clinical portfolio, owning dose strategy from first-in-human through registrational development. Leads quantitative approaches including population PK, PK/PD, PBPK and QSP, represents the company in health authority interactions, and builds a high-performing function within an AI-native TechBio.

Recursion OS

Last week

GSK · 10000+ people · Public

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

  • Zug, Switzerland
  • Hybrid · 2 days in office
  • US$340,500 – US$567,500 pa
  • Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and serves as asset spokesperson to senior governance boards.

mRNA · Checkpoint Inhibitors

Last month

GSK · 10000+ people · Public

Manager / Associate Director - Global Regulatory Strategy (Respiratory, Immunology & Inflammation)

  • London
  • Hybrid · 2–3 days in office
  • Director

Develops and executes global and regional regulatory strategies for assigned assets in the Respiratory, Immunology & Inflammation therapeutic group, managing regulatory interactions, submissions and review processes across regions. Ensures compliance with internal GSK processes and regulatory requirements to secure optimal labelling, working closely with global counterparts and commercial teams.

AI

Last week

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - Lung

  • Waltham, United States
  • On-site
  • US$242,550 – US$404,250 pa
  • Director · manages people

Senior physician leader providing medical oversight, safety monitoring and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional matrix teams on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence at least two days a week at a GSK site in Switzerland, the UK or the US.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - Lung

  • Stevenage
  • On-site
  • US$242,550 – US$404,250 pa
  • Director · manages people

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional Clinical Matrix Team on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires deep lung cancer drug development expertise including early phase trials.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - Lung

  • Zug, Switzerland
  • On-site
  • US$242,550 – US$404,250 pa
  • Director · manages people

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional groups on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence of at least two days a week at a GSK site.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - GU

  • London
  • On-site
  • US$284,250 – US$473,750 pa
  • Director

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - GU

  • Waltham, United States
  • On-site
  • US$284,250 – US$473,750 pa
  • Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds relationships with key external experts and represents the company at advisory boards and medical meetings.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - GU

  • Stevenage
  • On-site
  • US$284,250 – US$473,750 pa
  • Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - GU

  • Zug, Switzerland
  • On-site
  • US$284,250 – US$473,750 pa
  • Director

Leads clinical development for GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - Sarcoma

  • London
  • On-site
  • US$284,250 – US$473,750 pa
  • Director · manages people

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across sarcoma oncology studies, from protocol design through regulatory interactions. Serves on the Clinical Matrix Team, mentors Medical Directors and engages external experts, with a minimum two days a week on-site presence.

Real World Evidence

Last month

Get new london roles by email. One email a week when new roles match, or daily if you prefer. Stop any time.

Filters

Are you sure?